Old Republic International Corp Abb Vie Inc. Transaction History

Old Republic International Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $63 Million - $78.1 Million	-477,200 Reduced 61.8%	295,000 $47.8 Million
Q2 2021 Jul 29, 2021	BUY	$105.21 - $117.21 $21 Million - $23.4 Million	200,000 Added 34.95%	772,200 $87 Million
Q4 2019 Jan 29, 2020	BUY	$72.13 - $90.25 $7.79 Million - $9.75 Million	108,000 Added 23.27%	572,200 $50.7 Million
Q3 2019 Oct 31, 2019	BUY	$62.98 - $75.72 $6.36 Million - $7.65 Million	101,000 Added 27.81%	464,200 $35.1 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $4.47 Million - $5.71 Million	68,000 Added 23.04%	363,200 $26.4 Million
Q3 2017 Nov 01, 2017	BUY	$69.85 - $89.22 $20.6 Million - $26.3 Million	295,200	295,200 $26.2 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Old Republic International Corp, based on Form 13F filings with the SEC.

Stay updated on Old Republic International Corp with notifications on news.